LOGAN SUSSMAN: Open Payments
NPI 1043967078 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,903 in 94 payments from 19 companies in 2025. Trend: 2023 $2,076 · 2024 $2,299 · 2025 $1,903
Food & beverage: $1,761Education: $142
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $379 |
| ABBVIE INC. | 18 | $289 |
| LEO Pharma Inc. | 12 | $200 |
| Amgen Inc. | 9 | $169 |
| UCB, Inc. | 5 | $138 |
| REVANCE THERAPEUTICS, INC. | 1 | $115 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $89 |
| Incyte Corporation | 4 | $84 |
| GENZYME CORPORATION | 2 | $75 |
| Organon LLC | 4 | $58 |
Products named: TREMFYA, SKYRIZI, OTEZLA, Bimzelx, ADBRY, DAXXIFY, OPZELURA, ANZUPGO.
Industry payments across NV — which companies pay providers there.
